GRFS

Grifols SA ADR

8.10

Oct 30 • 3:59 PM ET +0.06 (0.75%)

8.10

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - General Spain Mid NASD

Peers: ADMA TAK HAE KMDA ARGX QDEL SNY GSK CERS IMVT

| Held by: IBB BINV BSMC KOMP SPDW CGIC APIE QQQS IBBQ AVNC

Scroll to Statements

Index	-
Market Cap	2.09B
Enterprise Value	14.03B
Income	527.19M
Sales	8.65B
Book/sh	9.32
Cash/sh	2.27
Dividend Est.	0.24 (3.01%)
Dividend TTM	0.11 (1.31%)
Dividend Ex-Date	Jul 02, 2026
Dividend Gr. 3/5Y	- -8.05%
Payout	34.22%
Employees	25258
IPO	Jun 02, 2011

P/E	10.45
Forward P/E	6.59
PEG	0.29
P/S	0.24
P/B	0.87
P/C	3.57
P/FCF	2.21
EV/EBITDA	7.30
EV/Sales	1.62
Quick Ratio	0.81
Current Ratio	2.37
Debt/Eq	1.54
LT Debt/Eq	1.46
Option/Short	Yes / Yes

EPS (ttm)	0.77
EPS next Y	1.23
EPS next Q	-
EPS this Y	14.57%
EPS next Y	25.87%
EPS next 5Y	22.85%
EPS past 3/5Y	27.36% -8.34%
Sales past 3/5Y	10.04% 6.88%
EPS Y/Y TTM	61.67%
Sales Y/Y TTM	6.84%
EPS Q/Q	34.78%
Sales Q/Q	1.65%
Earnings	Jul 28 AMC
EPS/Sales Surpr.	-26.24% -6.10%

Insider Own	0.06%
Insider Trans	0.00%
Inst Own	56.41%
Inst Trans	4.05%
ROA	2.28%
ROE	8.50%
ROIC	3.38%
Gross Margin	36.98%
Oper. Margin	16.23%
Profit Margin	6.09%
SMA20	6.42%
SMA50	6.70%
SMA200	1.27%
Trades

Shs Outstand	258.22M
Shs Float	258.07M
Short Float	2.71%
Short Ratio	12.95
Short Interest	6.99M
52W High	9.90 -18.18%
52W Low	6.96 16.38%
Volatility	3.41% 2.39%
ATR (14)	0.21
RSI (14)	66.73
Beta	0.77
Rel Volume	1.49
Avg Volume	539.87K
Volume	803,401

Perf Week	7.14%
Perf Month	10.96%
Perf Quarter	3.05%
Perf Half Y	-1.58%
Perf YTD	-13.37%
Perf Year	-11.57%
Perf 3Y	3.05%
Perf 5Y	-38.22%
Perf 10Y	-44.14%
Recom	2.67
Target Price	11.30
Prev Close	8.04
Price	8.10
Change %	0.75%

Consensus

Hold

Avg. Price Target

$11.30

Implied Upside

+39.5%

Analysts9incl. previous ratings

Rating Distribution6 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change
Feb 12, 2025	Resumed	MMorgan Stanley	Overweight
Mar 12, 2024	Downgrade	DDeutsche Bank	Hold → Sell
Apr 12, 2023	Upgrade	MMorgan Stanley	Equal-Weight → Overweight
Mar 03, 2023	Downgrade	MMorgan Stanley	Overweight → Equal-Weight
Feb 16, 2023	Upgrade	BBarclays	Underweight → Equal Weight
Jan 18, 2023	Upgrade	JJefferies	Hold → Buy
Apr 08, 2022	Initiated	MMorgan Stanley	Equal-Weight
Nov 05, 2021	Downgrade	DDeutsche Bank	Buy → Hold
Oct 19, 2021	Downgrade	BBarclays	Overweight → Underweight
Oct 06, 2021	Upgrade	CCitigroup	Neutral → Buy
Jun 14, 2021	Upgrade	DDeutsche Bank	Hold → Buy
Apr 20, 2021	Initiated	DDeutsche Bank	Hold
Mar 23, 2021	Upgrade	CCredit Suisse	Neutral → Outperform
Mar 11, 2021	Upgrade	HHSBC Securities	Hold → Buy
Oct 01, 2020	Upgrade	CCitigroup	Sell → Neutral
Jun 09, 2020	Upgrade	HHSBC Securities	Reduce → Hold
Jun 09, 2020	Downgrade	CCitigroup	Neutral → Sell
Mar 25, 2020	Downgrade	CCitigroup	Buy → Neutral
Jun 27, 2019	Upgrade	JJP Morgan	Neutral → Overweight
Feb 08, 2019	Downgrade	BBerenberg	Buy → Hold

Aug-10-26 07:00AM	Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Jul-28-26 09:01PM	Grifols SA (GRFS) (H1 2026) Earnings Call Highlights: Strong Biopharma Growth and Strategic ... (GuruFocus.com)
Jul-16-26 08:00AM	Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins (GlobeNewswire)
Jun-15-26 08:00AM	Grifols Launches FESILTY (fibrinogen, human-chmt) in the U.S. (GlobeNewswire)
May-07-26 01:04PM	Grifols shares slide 4% as margin miss soured Q1 profit jump (Investing.com)
08:28AM	Loading…
Mar-17-26 08:28AM	Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease (GlobeNewswire)
Mar-10-26 06:45AM	Grifols slides as Morgan Stanley downgrades on uncertain growth outlook (Investing.com) -6.39%
Feb-26-26 08:01PM	Grifols SA (GRFS) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Jan-22-26 09:13AM	ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? (Zacks)
Nov-06-25 09:35AM	Down 10.4% in 4 Weeks, Here's Why Grifols (GRFS) Looks Ripe for a Turnaround (Zacks)
Nov-04-25 08:13PM	Grifols SA (GRFS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... (GuruFocus.com) -6.40%
Oct-30-25 09:40AM	Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-27-25 11:40AM	GRFS vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Are Investors Undervaluing Grifols (GRFS) Right Now? (Zacks)
Oct-10-25 11:40AM	GRFS vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
09:40AM	Loading…
09:40AM	Is Grifols (GRFS) Stock Undervalued Right Now? (Zacks)
Sep-24-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Sep-11-25 11:11AM	Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility (Insider Monkey)
Sep-08-25 04:59PM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Aug-28-25 12:00PM	All You Need to Know About Grifols (GRFS) Rating Upgrade to Buy (Zacks)
Aug-20-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are Investors Undervaluing Grifols (GRFS) Right Now? (Zacks)
Jul-31-25 05:43AM	New Strong Sell Stocks for July 31st (Zacks)
Jun-27-25 08:11AM	Will Strong Asceniv Sales Drive ADMA Biologics Further? (Zacks)
Jun-16-25 01:06PM	ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? (Zacks)
Jun-06-25 10:40AM	ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold? (Zacks)
Jun-05-25 12:00PM	Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know (Zacks)
Jun-03-25 09:40AM	Is Grifols (GRFS) Stock Undervalued Right Now? (Zacks)
Jun-02-25 11:40AM	GRFS vs. STVN: Which Stock Is the Better Value Option? (Zacks)
04:05PM	Loading…
May-30-25 04:05PM	Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting (Business Wire)
May-28-25 10:01AM	ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy? (Zacks)
May-22-25 05:34AM	FDA clears Grifols application for dry eye disease treatment (Clinical Trials Arena)
May-15-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
May-13-25 11:48AM	Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year (TipRanks)
11:46AM	Grifols reaffirms guidance for 2025 (TipRanks)
May-08-25 01:26PM	ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock? (Zacks)
May-01-25 01:22PM	Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? (Zacks)
Apr-30-25 06:17AM	Australia's CSL evaluates China tariff exemptions for its US-made drugs (Reuters)
Apr-28-25 08:40AM	Here's White Falcon's Views on Grifols, S.A. (GRFS) (Insider Monkey)
Apr-23-25 11:10AM	Grifols: A Market Setback Turns Into Buying Opportunity (Seeking Alpha)
10:50AM	White Falcon Capital Q1 2025 Partner's Letter (Seeking Alpha)
Apr-09-25 06:32AM	IBL partners with Grifols to develop biomarker panels for speciality diagnostics (Medical Device Network) +6.78%
Apr-02-25 07:27AM	Stocks to Watch Wednesday: Tesla, Nvidia, Newsmax, Novo Nordisk (The Wall Street Journal) +7.61%
03:03AM	Spanish pharma company Grifols' shares up on Brookfield talk (Reuters)
Feb-27-25 09:16AM	Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now? (Insider Monkey)
06:00AM	Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com)
Jan-22-25 10:22AM	Gotham, Grifols Eye Two Separate Regulator Reports Ahead of Legal Standoff (Bloomberg)
Jan-14-25 06:00AM	Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease (GlobeNewswire)
Jan-13-25 10:55AM	Mason Capital complains about Grifols' transparency to Spanish regulator (Reuters)
10:00AM	Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols (Business Wire)
Dec-13-24 05:24AM	Grifols Worst-Ever Year Cant Derail Analyst Calls to Buy (Bloomberg)
04:14AM	Grifols Keeps Door Open to Brookfield With Special Bond Term (Bloomberg)
Dec-10-24 01:07PM	Flat Footed Asks Grifols to Reform Board to Protect Shareholders (Bloomberg)
Dec-06-24 10:34AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Dec-05-24 03:40AM	SEC Drops Probe Into Gotham Over Report on Grifols Accounts (Bloomberg)
Dec-04-24 02:30AM	Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga (Business Wire)
Dec-03-24 05:13AM	Grifols Shareholder Mason Capital Calls for Board Overhaul (Bloomberg)
Nov-29-24 09:29AM	Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday? (Benzinga) -13.38%
Nov-28-24 07:39AM	Billionaire Grifols Family Woes in Focus as Brookfield Exits (Bloomberg)
07:09AM	Grifols In Talks to Refinance Debt, Credit Line, CEO Says (Bloomberg)
Nov-27-24 09:02AM	Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols (Bloomberg) -7.45%
06:58AM	Brookfield Set to Drop Grifols Bid as Family Shuns Others (Bloomberg)
Nov-20-24 07:30AM	GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment (Clinical Trials Arena)
02:16AM	Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (Bloomberg)
Nov-19-24 11:16PM	Analyst Report: Grifols, S.A. (Morningstar Research) -8.24%
08:00AM	GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus (GlobeNewswire)
07:33AM	Brookfield Weighs 6.45 Billion Bid for Grifols; Shares Drop (Bloomberg)
02:30AM	Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors (Business Wire)
Nov-14-24 11:37AM	Banks to Pitch Roughly 11 Billion Buyout Debt for Grifols (Bloomberg) +5.06%
Nov-08-24 06:01PM	Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ... (GuruFocus.com)
03:54PM	Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors (Business Wire)
10:27AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Nov-05-24 12:02PM	Brookfield Seeks More Information on Grifols Related-Party Deals (Bloomberg) +5.57%
Oct-30-24 08:28AM	Grifols receives FDA approval to treat surgical bleeding with FS solution (TipRanks) +6.95%
Oct-29-24 08:00AM	Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution (GlobeNewswire)
Oct-22-24 08:00AM	Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury (GlobeNewswire)
Oct-03-24 08:00AM	GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat (GlobeNewswire)
Sep-19-24 04:00PM	Grifols Investor Group With 7.7% Holding Seeks Seat on Board (Bloomberg)
Sep-10-24 01:37PM	Grifols Holders Call on Family, Brookfield to Offer Fair Price (Bloomberg)
Sep-03-24 05:41AM	Grifols Postpones Capital Markets Day Amid Potential Takeover (Bloomberg)
Aug-29-24 12:22PM	Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid (Bloomberg)
Aug-26-24 07:00AM	This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future (The Wall Street Journal)
Aug-22-24 11:01AM	Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday (Zacks) +15.38%
Aug-21-24 12:19PM	Brookfield in talks with banks for funding Grifols' takeover bid, sources say (Reuters) +6.68%
05:33AM	Brookfield Seeks Nearly 10 Billion to Back Grifols Takeover (Bloomberg)
05:14AM	Grifols shares up on potential takeover by Brookfield (Investing.com)
Aug-07-24 07:02PM	Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA (GuruFocus.com)
Aug-02-24 01:21PM	Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again - Hagens Berman (Business Wire)
Jul-31-24 12:27PM	Grifols: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 (GlobeNewswire)
Jul-30-24 07:42PM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:35AM	Grifols Cuts Chinese Stake Value by 457 Million After Audit (Bloomberg)
Jul-29-24 08:00AM	Grifols receives expanded XEMBIFY (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients (GlobeNewswire)
Jul-09-24 11:28AM	Grifols Family Shareholders, Brookfield in Talks To Take Firm Private (Investopedia)
Jul-08-24 01:00PM	3 Stocks to Buy From the Ultimate' Buy-and-Hold Portfolio (InvestorPlace) +19.46%
12:36PM	GRFS Stock Alert: Grifols Pops 20% on Takeover Interest (InvestorPlace)
11:36AM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:16AM	Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why (Benzinga)
07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)

Show Previous News

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

CEO & DirectorMr. Jose Ignacio Abia Buenache

Chief Financial OfficerMr. Rahul Srinivasan

Senior Vice President of Strategy & COO OfficeMr. Lluis Pons Gomez

Head of Investor Relations & Sustainability and Vice PresidentDaniel Segarra

Chief Corporate Affairs & Legal OfficerMr. David Ian Bell

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRFS

Grifols SA ADR

Upgrade your Finviz experience